Ashton William
Director at SPECTRUM PHARMACEUTICALS INC; Director at Sucampo Pharmaceuticals, Inc.
- Sold, on record
- $2.4M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Jun 21, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- SPECTRUM PHARMACEUTICALS INCDirector
- Sucampo Pharmaceuticals, Inc.Director
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Sucampo Pharmaceuticals, Inc.129,766 shares
- SPECTRUM PHARMACEUTICALS INC24,950 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Sucampo Pharmaceuticals, Inc.UnusualMar 12 2015
Sold 129,766 shares at $17.42 ($2.3M)
Ashton William, Director
Sold 100% of holdings ($2.3M position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale SPECTRUM PHARMACEUTICALS INCUnusualJun 20 +1561 days
Sold 6,667 shares at $8.57 ($57k)
Ashton William, Director
Sold 50% of holdings ($114k position)6,666 shares leftFirst sale on recordFiling
- 3 Form 4 sale SPECTRUM PHARMACEUTICALS INCPlan not statedJun 22 +368 days
Sold 5,000 shares at $3.25 ($16k)
Ashton William, Director
Sold 10.7% of holdings ($152k position)41,666 shares leftFiling
- 4 Form 4 sale SPECTRUM PHARMACEUTICALS INCPlan not statedJun 18 +361 days
Sold 9,000 shares at $4.24 ($38k)
Ashton William, Director
Sold 16.1% of holdings ($237k position)46,943 shares leftFiling
- 5 Form 4 sale SPECTRUM PHARMACEUTICALS INCPlan not statedJun 21 +368 days
Sold 4,283 shares at $0.79 ($3k)
Ashton William, Director
Sold 9.1% of holdings ($37k position)42,660 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jun 21, 2022 | SPECTRUM PHARMACEUTICALS INC | Director | Form 4 sale | 4,283 | $3k | 9.1% | Plan not stated | SEC |
| Jun 18, 2021 | SPECTRUM PHARMACEUTICALS INC | Director | Form 4 sale | 9,000 | $38k | 16.1% | Plan not stated | SEC |
| Jun 22, 2020 | SPECTRUM PHARMACEUTICALS INC | Director | Form 4 sale | 5,000 | $16k | 10.7% | Plan not stated | SEC |
| Jun 20, 2019 | SPECTRUM PHARMACEUTICALS INC | Director | Form 4 sale | 6,667 | $57k | 50.0% | Unusual | SEC |
| Mar 12, 2015 | Sucampo Pharmaceuticals, Inc. | Director | Form 4 sale | 129,766 | $2.3M | 100.0% | Unusual | SEC |